This Prized Stock Remains a Bargain ($3 Range)Institutional investors are plowing into one American medtech... That's because it's hugely disruptive (already in all top 100 hospitals)... and has a patent moat protecting future profits. In fact, in the most recent quarterly report, these funds added to their stakes despite the 2022 market downturn: - Dynamic Advisor Solutions: 15,210 new shares
- Cetera Advisor Networks: 1,856 new shares
- Arizona State Retirement System: 2,363 new shares
- Principal Financial Group: 2,994 new shares
- ProShare Advisors: 3,874 new shares.
And legendary medtech investor Larry Robbins personally loaded up on 500,000 new shares worth $1.87 million. Yet you can get your hands on this award-winning medtech today for a cheaper price than Robbins gladly paid. Yours in smart speculation, Karim Rahemtulla, Head Fundamental Tactician Monument Traders Alliance P.S. Hurry, as this stock has jumped from $2.92 on June 16 to as high as $3.50 since (+20%). Urgent details in this special briefing. |
No comments:
Post a Comment